Welcome to our dedicated page for Datametrex Ai Li news (Ticker: DTMXF), a resource for investors and traders seeking the latest updates and insights on Datametrex Ai Li stock.
Datametrex Ai Li (DTMXF) delivers innovative AI solutions across healthcare and technology sectors through strategic partnerships and operational excellence. This news hub provides verified updates on corporate developments, financial milestones, and technological advancements essential for informed analysis.
Access real-time updates on earnings reports, AI implementation progress, healthcare system integrations, and strategic restructuring efforts. Our curated news collection serves investors and industry observers with:
• AI deployment timelines in clinical settings
• IT service expansion in key global markets
• Partnership announcements with healthcare providers
• Financial performance updates and strategic pivots
Bookmark this page for vetted information on DTMXF's progress in merging artificial intelligence with practical healthcare solutions and enterprise IT services. Regular updates ensure you maintain current awareness of the company's market positioning and technological roadmap.
Datametrex AI (TSXV:DM, FSE:D4G, OTC Pink:DTMXF) has successfully closed the final tranche of its non-brokered private placement financing, raising gross proceeds of $565,000. This brings the aggregate total to $1,521,909.30 across all 3 tranches. The final tranche consisted of 28,250,000 units at $0.02 per unit, each comprising one common share and one warrant. Warrants are exercisable at $0.05 for two years. Insiders participated with $190,000. The proceeds will be used for general corporate and working capital purposes. CEO Charles Park expressed delight in the successful closing, emphasizing investor trust and the financing's importance for growth and shareholder value.
Datametrex AI (TSXV: DM) (OTC Pink: DTMXF) has been granted a 30-day extension until August 29, 2024, to complete its non-brokered private placement of up to 75,000,000 units for total gross proceeds of up to $1,500,000. The company has successfully closed the first tranche of $645,000 and the second tranche of $311,409.29. Each unit consists of one common share and one warrant, with each warrant exercisable at CAD $0.05 for two years.
The net proceeds will be used for general corporate and working capital purposes. CEO Charles Park expressed satisfaction with the progress of the financing, stating it demonstrates investor confidence in the company's vision and capabilities.
Datametrex AI (OTC Pink: DTMXF) has closed the first tranche of its non-brokered private placement, raising $645,500 through the issuance of 32,275,000 units at $0.02 per unit. Each unit consists of one common share and one warrant, with warrants exercisable at $0.05 per share for two years. The proceeds will be used for general working capital. Notably, insiders subscribed for 3,000,000 units, classified as a related party transaction under MI 61-101 but exempt from formal valuation and minority approval requirements. The securities are subject to a four-month hold period as per Canadian laws.
Datametrex AI announced the addition of two new physicians to Imagine Health Centres. This move is expected to increase the annual revenue of the medical clinics by approximately $450,000 and improve the gross margin by $130,000. The addition aligns with the company's goal to enhance healthcare services and patient outcomes in Alberta. CEO Charles Park expressed excitement about the physicians' diverse backgrounds and dedication to patient care, anticipating a significant positive impact on the clinics and communities.
Datametrex AI (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) has announced the launch of its new play-to-earn game, Cereal Crunch, on the Google Play Store. This follows the company's recent acquisition of the game. Additionally, Datametrex has proposed a non-brokered private placement financing aiming to raise $1,500,000 by offering up to 75 million units at $0.02 per unit. Each unit includes one common share and one share purchase warrant, exercisable at $0.05 per share for three years. The raised funds will be used for general working capital. The closure of the private placement is expected around June 27, 2024, and is subject to TSX Venture Exchange approval. The game, which uses match-3 mechanics, includes in-game purchases and advertisements for revenue generation, with plans to integrate blockchain-based Crunch Tokens for secure transactions. Datametrex also aims to launch Cereal Crunch on the Apple Play Store soon.
Datametrex AI has completed the acquisition of the mobile blockchain game Cereal Crunch from Sariel Diagnostics Corp. for $3.5 million. The deal includes game software, IP, user databases, the Crunch Token, and $150,000 in cash. Cereal Crunch features match-3 mechanics and a play-to-earn model rewarding players with cryptocurrency. The payment was made through the issuance of 70,000,000 common shares of Datametrex at $0.05 per share. This acquisition aligns with Datametrex's strategic focus on innovative technologies in e-gaming and blockchain sectors. All issued shares are under a statutory hold period of four months and one day.
Datametrex AI (TSXV: DM, FSE: D4G, OTC Pink: DTMXF) announced the sale of 4,570,000 common shares of New World Solutions Inc. (CSE: NEWS) at an average price of $0.02 per share, generating approximately $95,065 in proceeds. Before the sale, Datametrex held 11,500,000 shares, representing 11.14% of New World's outstanding shares. Post-sale, Datametrex retains 6,930,000 shares, now holding 6.71% of New World's shares—a 4.43% decrease in ownership. The sale was made for investment purposes, and the company may adjust its holdings based on market conditions.
Datametrex AI (OTC Pink: DTMXF) announced the passing of Hon. James Scott Peterson, a valued board member since July 2020, on May 10, 2024. Hon. Peterson, a former Member of Parliament, Minister of International Trade, and legal expert, contributed significantly to the company's strategic initiatives and governance. CEO Charles Park emphasized Peterson's pivotal role within the company and his lasting legacy. The company extends condolences to his family and friends.